Feature Channels:

Immunology

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

ESGC, glottic cancer, HFX, hypofractionated radiotherapy, Journal Of The National Cancer Institute, Yale Cancer Center

Yale Researchers Identify Optimal Therapy for Patients with Early-Stage Glottic Cancer (Vocal Chord Cancer)

ESGCOSfigure_2.jpg

Radiotherapy alone is often used to treat early-stage glottic cancer (ESGC), a cancer of the vocal chords, however, the optimal radiation treatment schedule remains unknown, until now.

Medicine

Channels:

Immunotherapy, Maraba, non-small cell lung cancer

Hamilton Patient First to Receive Experimental Immunotherapy Combination for Cancer in Clinical Trial

Experts at Hamilton Health Sciences (HHS) and McMaster University, in partnership with The Ottawa Hospital, have begun a clinical trial to determine if the unique experimental immunotherapy combination may be able to treat non-small cell lung cancer. The experimental therapy combines two different viruses with an approved drug to stimulate the immune system to recognize and attack cancer cells.

Medicine

Channels:

Glaucoma in Developing Countries, Reversing Retinitis Pigmentosa, Eye Expressions, and More in the Vision News Source

The latest research and feature news on vision in the Vision News Source

Medicine

Channels:

Cancer, Ovarian Cancer, Biomarker, Cancer Research, NY-ESO-1, Immunotherapy, Targeted Therapy, Tumor Antigens

Roswell Park-Led Team Identifies Tumor Marker for Aggressive Ovarian Cancer

KunleOdunsiwithGYNPatient2013-08-283.jpg

Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published online ahead of print in the journal Gynecologic Oncology.

Medicine

Channels:

Cancer, Research, Immunotherapy, CAR T cells, Cellular Therapy, Biotechnology, Biomedical, Solid Tumors, Biopolymer

Implanted Scaffold with T Cells Rapidly Shrinks Tumors

3.jpg

A biopolymer structure enriched with nutrients shows how immunotherapy could be adapted for solid tumors, according to study in The Journal of Clinical Investigation.

Medicine

Science

Channels:

Preeclampsia, Immune

Altered Immune Cells May Both Contribute to Preeclampsia and Offer New Hope for Treatment

In a new study presented today at the APS annual meeting at Experimental Biology 2017, researchers have found that the immune system’s natural killer (NK) cells activate and change in response to placental ischemia. Disrupting these altered cells seems to blunt some of the dangerous complications of the condition, including high blood pressure (hypertension) and inflammation in the mother and growth restriction in the fetus.

Medicine

Channels:

VR in the OR, Healthy Volunteers, Preventing HIV among Youth, and More in the Healthcare News Source

The latest research, features and announcements in healthcare in the Healthcare News Source

Science

Channels:

Bladder Cancer, bladder cancer clinical trial, bladder cancer metastasis, bladder, bladder cancer treatment, atezolizumab, FDA Approval, FDA, FDA Cleared, bladder tumor, checkpoint inhibitors

NYU Langone Research Leads to Accelerated Approval of Bladder Cancer Immunotherapy Drug

Arjun-Balar-Patient-8.jpg

Findings from a clinical trial led by a researcher at NYU Langone’s Perlmutter Cancer Center helped pave the way for the recent, accelerated approval by the U.S. Food and Drug Administration (FDA) of a highly effective immunotherapy as first line treatment for patients with advanced bladder cancer who are not eligible for treatment with standard chemotherapy

Medicine

Channels:

GW School of Medicine and Health Sciences, HIVAIDS, BELIEVE grant, NIH, HIV cure research, HIV Reservoirs, AIDS, HIV

Defective HIV Proviruses Reduce Effective Immune System Response, Interfere with HIV Cure

A new study finds defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV. The study was published by researchers at the George Washington University and Johns Hopkins University in Cell Host & Microbe.

Medicine

Life

Arts and Humanities

Channels:

Cancer, Immunotherapy, Cancer Moonshot, Philanthropy, text2give, Rock And Roll, Concert, Poison, Rikki Rockett

Rock Tour “Text2Give” Supports Immunotherapy at UC San Diego Health

Rock star drummer Rikki Rockett feels very lucky to be on tour with his band, Poison, this spring. A year ago, he didn’t know if he would survive tongue cancer. But after participating in an immunotherapy clinical trial at Moores Cancer Center at UC San Diego Health, he was declared cancer-free in July 2016. To give back, Rockett is now asking concert-goers to join him in supporting immunotherapy at Moores Cancer Center.







Chat now!